We’re proud to share that Corporis Medical successfully hosted DEKRA last month for our annual ISO 13485 audit and our initial EU MDR 2017/745 audit.

We’re thrilled to share some fantastic news from the Corporis Medical team: Tina Šćasni has successfully defended her master’s thesis,

We’re excited to share a major milestone in the development of the second generation of our Mediclose System:

As our company continues to grow, so must our office space.

We’re thrilled to announce that our request to start our First-in-Human clinical investigation with Laprixa was approved from the METC and MUMC+ board! 🎉

We’re pleased to introduce Raoul Beex, who has recently joined our team!

We’re excited to introduce the latest innovation from Corporis Medical!

Maastricht, 20-01-2025

The journey toward sustainable healthcare has taken a significant step forward with the development of the Mediclose Cartridge System, an innovative approach to incision closure in laparoscopic surgery.

Our Mediclose team recently had the pleasure of visiting our incredible partner, Assut Europe, in beautiful Rome.

Today marks the successful launch of the OP-Zuid project STIM-00953, “Laprixa, the Intra-operative Predictor of Wound Healing Capacity”!

Corporis Medical CSO Dr. Alexander Veenhof has successfully completed the first in vivo test for our latest innovation, “the miniaturized Laprixa probe”.

This past Tuesday, the Corporis Medical team attended TEFAF Maastricht, courtesy of Brightlands.